Literature DB >> 18627674

Toward defining schizophrenia as a more useful clinical concept.

Jess G Fiedorowicz1, Eric A Epping, Michael Flaum.   

Abstract

Delineating schizophrenia remains elusive despite considerable interest and study for more than a century. During this time, a variety of terms and defining features have been ascribed to the construct. The predominant contemporary construct, for which substantial limitations persist, has changed little in the past 30 years. With the approaching arrival of the DSM-V, interest in the nosology of schizophrenia has rebounded. Recent publications have focused principally on the following: integrating dimensional approaches to diagnosis, subtypes of schizophrenia, endophenotypes, and identifying those at early risk as part of a staging process. Some have even suggested replacing the term. Although an etiopathic diagnosis remains out of reach, contemporary research is marching down several distinct paths toward defining schizophrenia as a construct of greater clinical utility.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18627674     DOI: 10.1007/s11920-008-0055-9

Source DB:  PubMed          Journal:  Curr Psychiatry Rep        ISSN: 1523-3812            Impact factor:   5.285


  49 in total

1.  Familiality of symptom dimensions in schizophrenia.

Authors:  H Wickham; C Walsh; P Asherson; C Taylor; T Sigmundson; M Gill; M J Owen; P McGuffin; R Murray; P Sham
Journal:  Schizophr Res       Date:  2001-03-01       Impact factor: 4.939

2.  Prolactin and estradiol serum levels in unmedicated male paranoid schizophrenia patients.

Authors:  Michael Segal; Avi Avital; Severina Berstein; Andrei Derevenski; Sergio Sandbank; Abraham Weizman
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2006-11-14       Impact factor: 5.067

3.  Renaming schizophrenia: a Japanese perspective.

Authors:  Mitsumoto Sato
Journal:  World Psychiatry       Date:  2006-02       Impact factor: 49.548

4.  Clinical staging: a heuristic model for psychiatry and youth mental health.

Authors:  Patrick D McGorry; Rosemary Purcell; Ian B Hickie; Alison R Yung; Christos Pantelis; Henry J Jackson
Journal:  Med J Aust       Date:  2007-10-01       Impact factor: 7.738

5.  Dimensions of delusional experience.

Authors:  K S Kendler; W M Glazer; H Morgenstern
Journal:  Am J Psychiatry       Date:  1983-04       Impact factor: 18.112

6.  Dimensions and classes of psychosis in a population cohort: a four-class, four-dimension model of schizophrenia and affective psychoses.

Authors:  V Murray; I McKee; P M Miller; D Young; W J Muir; A J Pelosi; D H R Blackwood
Journal:  Psychol Med       Date:  2005-04       Impact factor: 7.723

Review 7.  New directions in the conceptualization of psychotic disorders.

Authors:  Jerome L Kroll
Journal:  Curr Opin Psychiatry       Date:  2007-11       Impact factor: 4.741

8.  Long-term course of schizophrenic illness: Bleuler's study reconsidered.

Authors:  Jiri Modestin; Andreas Huber; Engin Satirli; Tina Malti; Daniel Hell
Journal:  Am J Psychiatry       Date:  2003-12       Impact factor: 18.112

9.  Physiology of schizophrenia, bipolar disorder, and schizoaffective disorder.

Authors:  Laura F Martin; Mei-Hua Hall; Randal G Ross; Gary Zerbe; Robert Freedman; Ann Olincy
Journal:  Am J Psychiatry       Date:  2007-12       Impact factor: 18.112

10.  Fabp7 maps to a quantitative trait locus for a schizophrenia endophenotype.

Authors:  Akiko Watanabe; Tomoko Toyota; Yuji Owada; Takeshi Hayashi; Yoshimi Iwayama; Miho Matsumata; Yuichi Ishitsuka; Akihiro Nakaya; Motoko Maekawa; Tetsuo Ohnishi; Ryoichi Arai; Katsuyasu Sakurai; Kazuo Yamada; Hisatake Kondo; Kenji Hashimoto; Noriko Osumi; Takeo Yoshikawa
Journal:  PLoS Biol       Date:  2007-11       Impact factor: 8.029

View more
  8 in total

1.  DSM-IV "criterion A" schizophrenia symptoms across ethnically different populations: evidence for differing psychotic symptom content or structural organization?

Authors:  Duncan McLean; Rangaswamy Thara; Sujit John; Robert Barrett; Peter Loa; John McGrath; Bryan Mowry
Journal:  Cult Med Psychiatry       Date:  2014-09

Review 2.  Epigenetics and biomarkers in the staging of neuropsychiatric disorders.

Authors:  Trevor Archer; Richard J Beninger; Tomas Palomo; Richard M Kostrzewa
Journal:  Neurotox Res       Date:  2010-03-17       Impact factor: 3.911

3.  Oligodendroglial alterations and the role of microglia in white matter injury: relevance to schizophrenia.

Authors:  Li-Jin Chew; Paolo Fusar-Poli; Thomas Schmitz
Journal:  Dev Neurosci       Date:  2013-02-27       Impact factor: 2.984

Review 4.  Epigenetic mediation of environmental influences in major psychotic disorders.

Authors:  Bart P F Rutten; Jonathan Mill
Journal:  Schizophr Bull       Date:  2009-09-25       Impact factor: 9.306

5.  Comparing schizophrenia symptoms in the Iban of Sarawak with other populations to elucidate clinical heterogeneity.

Authors:  Duncan McLean; Robert Barrett; Peter Loa; Rangaswamy Thara; Sujit John; John McGrath; Jake Gratten; Bryan Mowry
Journal:  Asia Pac Psychiatry       Date:  2013-08-22       Impact factor: 2.538

6.  New visual information processing abnormality biomarker for the diagnosis of Schizophrenia.

Authors:  Ivan Koychev; Wael El-Deredy; John Francis William Deakin
Journal:  Expert Opin Med Diagn       Date:  2011-07-01

7.  Multinational comparative cross-sectional survey of views of medical students about acceptable terminology and subgroups in schizophrenia.

Authors:  Shanaya Rathod; Muhammad Irfan; Rachna Bhargava; Narsimha Pinninti; Joseph Scott; Haifa Mohammad Algahtani; Zhihua Guo; Rishab Gupta; Pallavi Nadkarni; Farooq Naeem; Fleur Howells; Katherine Sorsdahi; Kerensa Thorne; Victoria Osman-Hicks; Sasee Pallikadavath; Peter Phiri; Hannah Carr; Lizi Graves; David Kingdon
Journal:  BMJ Open       Date:  2018-06-07       Impact factor: 2.692

8.  Examining a staging model for anorexia nervosa: empirical exploration of a four stage model of severity.

Authors:  Sarah Maguire; Lois J Surgenor; Daniel Le Grange; Hubert Lacey; Ross D Crosby; Scott G Engel; Kirsty M Fromholtz; Bryony Bamford; Stephen Touyz
Journal:  J Eat Disord       Date:  2017-11-27
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.